Gastroparesis Trial, Recruiting (NCT06401746)

Gastroparesis Trial, Recruiting NCT06401746 Sponsor: University of Western Sydney Condition: Gastroparesis

Printed from Voxsanity (voxsanity.com.au) — NCT06401746 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Gastroparesis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are over 18 years old
You do not have any stomach or digestive symptoms (based on a standard medical checklist called the Rome IV criteria)
If you have type 2 diabetes: your blood sugar control marker (HbA1c) is above 7%, which indicates your diabetes is not fully controlled
If you have type 2 diabetes: your fasting blood sugar level is below 15 mmol/L (a blood test taken before eating)

Who may not be able to join:

You have used Ozempic, a similar diabetes/weight-loss injection medication (called GLP-1 receptor agonists), or regular insulin in the past 3 months
You have been diagnosed with a condition called gastroparesis (delayed stomach emptying), confirmed by a specific scan
You are currently pregnant or breastfeeding
You are unable to take part in a specific stomach monitoring test (called a BSGM test) — this includes people with a history of severe skin allergies or reactions to cosmetics or lotions, people with damaged, fragile, or inflamed skin on the upper belly area, or people who are unable to lie back in a relaxed, reclined position for the duration of the test

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Vincent Ho, MBBS, FRACP, FACP, PhD, Western Sydney University

Phone: +61 2 4634 4579

Australian sites

Western Sydney University, Campbelltown, New South Wales
+61 2 4634 4579

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06401746

Sponsor: University of Western Sydney

Phase: Not Applicable

Status: Recruiting

Condition: Gastroparesis

Trial contact: +61 2 4634 4579

More information: https://clinicaltrials.gov/study/NCT06401746

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are over 18 years old
You do not have any stomach or digestive symptoms (based on a standard medical checklist called the Rome IV criteria)
If you have type 2 diabetes: your blood sugar control marker (HbA1c) is above 7%, which indicates your diabetes is not fully controlled
If you have type 2 diabetes: your fasting blood sugar level is below 15 mmol/L (a blood test taken before eating)

Who may not be able to join:

You have used Ozempic, a similar diabetes/weight-loss injection medication (called GLP-1 receptor agonists), or regular insulin in the past 3 months
You have been diagnosed with a condition called gastroparesis (delayed stomach emptying), confirmed by a specific scan
You are currently pregnant or breastfeeding
You are unable to take part in a specific stomach monitoring test (called a BSGM test) — this includes people with a history of severe skin allergies or reactions to cosmetics or lotions, people with damaged, fragile, or inflamed skin on the upper belly area, or people who are unable to lie back in a relaxed, reclined position for the duration of the test

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Western Sydney

Registry

ClinicalTrials.gov

Start date

1 May 2024

Est. completion

13 March 2025

Where this trial is recruiting

🇦🇺 Australia

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Change in overall postprandial BSGM Gastric Alimetry Rhythm Index (minimum: 0; maximum: 1) on treatment compared to baseline (with a lower score meaning worse outcome).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov